Advertisement
Case Reports| Volume 61, ISSUE 6, 103498, December 2022

Combined immunoglobulin and plasmapheresis treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES)

Published:July 01, 2022DOI:https://doi.org/10.1016/j.transci.2022.103498
Combined immunoglobulin and plasmapheresis treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES)
Previous ArticleSpotlights on the latest opinions on identification, prevention, and management of newer CoV-2 variants: A roundup appraisal on innovative ideas and designer vaccines for Omicron
Next ArticleDecreased levels of ferritin, mild thrombocytosis, and increased erythropoietin are sequential events among frequent plateletpheresis donors: Implication for a ferritin screen

      Abstract

      Febrile infection-related epilepsy syndrome (FIRES) is a rarely observed and destructive syndrome progressing with resistant seizures or refractory status epilepticus. In this report we present in a treatment procedure with plasmapheresis of a pediatric patient with FIRES and currently unknown etiology in order to contribute to the literature.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Transfusion and Apheresis Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Hirsch L.J.
        • Gaspard N.
        • van Baalen A.
        • Nabbout R.
        • Demeret S.
        • Loddenkemper T.
        • et al.
        Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions.
        Epilepsia. 2018; 59: 739-744
        View in Article
        • Appenzeller S.
        • Helbig I.
        • Stephani U.
        • Haeusler M.
        • Kluger G.
        • Bungeroth M.
        • et al.
        Febrile infection‐related epilepsy syndrome (FIRES) is not caused by SCN1A, POLG,PCDH19 mutations or rare copy number variations.
        Dev Med Child Neurol. 2012; 54: 1144-1148
        View in Article
        • Van Baalen A.
        • Häusler M.
        • Boor R.
        • Rohr A.
        • Sperner J.
        • Kurlemann G.
        • et al.
        Febrile infection-related epilepsy syndrome (FIRES): a nonencephalitic encephalopathy in childhood.
        Epilepsia. 2010; 51: 1323-1328
        View in Article
        • Van Baalen A.
        • Häusler M.
        • Plecko-Startinig B.
        • Strautmanis J.
        • Vlaho S.
        • Gebhardt B.
        • et al.
        Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.
        Neuropediatrics. 2012; 43: 209-216
        View in Article
        • Caraballo R.H.
        • Reyes G.
        • Avaria M.F.
        • Buompadre M.C.
        • Gonzalez M.
        • Fortini S.
        • et al.
        Febrile infection related epilepsy syndrome: a study of 12 patients.
        Seizure. 2013; 22: 553-559
        View in Article
        • Serino D.
        • Santarone M.E.
        • Caputo D.
        • Fusco L.
        Febrile infection-related epilepsy syndrome (FIRES): prevalence, impact and management strategies.
        Neuropsychiatr Dis Treat. 2019; 15: 1897-1903
        View in Article
        • Zeiler F.A.
        • Matuszczak M.
        • Teitelbaum J.
        • Kazina C.J.
        • Gillman L.M.
        Plasmapheresis for refractory status epilepticus Part II: a scoping systematic review of the pediatric literatüre.
        Seizure. 2016; 43: 61-68
        View in Article
        • Montgomery R.A.
        • Loupy A.
        • Segev D.L.
        Antibody‐mediated rejection: new approaches in prevention and management.
        Am J Transplant. 2018; 18: 3-17
        View in Article
        • Kesici S.
        • Tanyıldız M.
        • Yetimakman F.
        • Bayrakci B.
        A novel treatment strategy for severe Guillain-Barré syndrome: zipper method.
        J Child Neurol. 2019; 34: 277-283
        View in Article

      10. Baglan E. , Ozdel S. , Uysal Yazıcı M. , Azapağası E. , Çelik H. , Yüksel D. et al. , A novel therapeutic approach using the Zipper method to treat chorea in a pediatric-onset systemic lupus erythematosus patient. Lupus, 0961203320984013.

        View in Article

      Article info

      Publication history

      Published online: July 01, 2022
      Accepted: June 30, 2022
      Received in revised form: June 15, 2022
      Received: May 18, 2022

      Footnotes

      ☆The work was developed at pediatric intensive care unit in Hatay State Hospital. We presented the work at XVI. Pediatric Emergency Medicine and Intensive Care Congress, TURKEY, 2–5 October 2019. We haven’t got any sources of financial support.

      Identification

      DOI: https://doi.org/10.1016/j.transci.2022.103498

      Copyright

      © 2022 Elsevier Ltd. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX